Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Abroad (travel likely)RecruitingPHASE4
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Medullary Thyroid Cancer
Locations
- Anhui Provincial Cancer Hospital, Hefei, Anhui, China
- Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, Beijing Municipality, China
- Gansu Cancer Hospital, Lanzhou, Gansu, China
- Guangxi Zhuang Autonomous Region Cancer Hospital (Affiliated Cancer Hospital of Guangxi Medical University), Nanning, Guangxi, China
- The First Affiliated Hospital of Hebei North University, Shijiazhuang, Hebei, China
- Tianjin Cancer Hospital, Tianjin, Hebei, China
- Henan Cancer Hospital, Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- Hubei Cancer Hospital, Wuhan, Hubei, China
- Hunan Cancer Hospital, Changsha, Hunan, China
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University, Nanjing, Jiangsu, China
- Jiangsu North People's Hospital, Yangzhou, Jiangsu, China
- Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
- The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
- Shanxi Provincial Tumor Hospital, Xi’an, Shanxi, China
- Tianjin People's Hospital, Tianjin, Tianjin Municipality, China
- The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China